Virginia Adamiak

Virginia Adamiak

Auto-generated profile, based on publicly available information

Virginia Adamiak

BC Cancer Agency 2 Vancouver, British Columbia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
AGAnn-Christin Gnirck
Ann-Christin Gnirck
MPMarie-Sophie Philipp
Marie-Sophie Philipp
AWAlex Waterhölter
Alex Waterhölter
MWMalte Wunderlich
Malte Wunderlich
NSNikhat Shaikh
Nikhat Shaikh
JTJan-Eric Turner
Jan-Eric Turner
Mucosal-associated invariant T (MAIT) cells have been implicated in various inflammatory diseases of barrier organs, but so far, their role in kidney disease is unclear. Here we report that MAIT cells that recognize their prototypical ligand, the vitamin B2 intermediate 5-OP-RU presented by MR1, reside in human and mouse kidneys. Single cell RNAseq analysis reveals several intrarenal MAIT subsets, and one, carrying the genetic fingerprint of tissue-resident MAIT17 cells, is activated and expanded in a murine model of crescentic glomerulonephritis (cGN). An equivalent subset is also present in kidney biopsies of patients with anti-neutrophil cytoplasmatic antibody (ANCA)-associated cGN. MAIT cell-deficient MR1 mice show aggravated disease, whereas B6-MAITCAST mice, harboring higher MAIT cell numbers, are protected from cGN. The expanded MAIT17 cells express anti-inflammatory mediators known to suppress cGN, such as CTLA-4, PD-1, and TGF-β. Interactome analysis predicts CXCR6 – CXCL16-mediated cross-talk with renal mononuclear phagocytes, known to drive cGN progression. In line, we find that cGN is aggravated upon CXCL16 blockade. Finally, we present an optimized 5-OP-RU synthesis method which we apply to attenuating cGN in mice. In summary, we propose that CXCR6+ MAIT cells might play a protective role in cGN, implicating them as a potential target for anti-inflammatory therapies.

29 September 2023 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
NSNikhat Shaikh
Nikhat Shaikh
AWAlex Waterhölter
Alex Waterhölter
AGAnn-Christin Gnirck
Ann-Christin Gnirck
MBMartina Becker
Martina Becker
VAVirginia Adamiak
Virginia Adamiak
JTJan-Eric Turner
Jan-Eric Turner
Adaptation of immune cells to tissue-specific microenvironments is a crucial process in homeostasis and inflammation. Here, we show that murine effector type 2 innate lymphoid cells (ILC2s) from various organs are equally effective in repopulating ILC2 niches in other anatomical locations where they adapt tissue-specific phenotypes of target organs. Single-cell transcriptomics of ILC2 populations revealed upregulation of retinoic acid (RA) signaling in ILC2s during adaptation to the small intestinal microenvironment, and RA signaling mediated reprogramming of kidney effector ILC2s toward the small intestinal phenotype in vitro and in vivo. Inhibition of intestinal ILC2 adaptation by blocking RA signaling impaired worm expulsion during Strongyloides ratti infection, indicating functional importance of ILC2 tissue imprinting. In conclusion, this study highlights that effector ILC2s retain the ability to adapt to changing tissue-specific microenvironments, enabling them to exert tissue-specific functions, such as promoting control of intestinal helminth infections.

1 April 2022 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
CRConstantin Rickassel
Constantin Rickassel
AGAnn-Christin Gnirck
Ann-Christin Gnirck
NSNikhat Shaikh
Nikhat Shaikh
VAVirginia Adamiak
Virginia Adamiak
AWAlex Waterhölter
Alex Waterhölter
JTJan-Eric Turner
Jan-Eric Turner
Innate lymphoid cells (ILCs) that express NK cell receptors (NCRs) and the transcription factor T-bet populate nonlymphoid tissues and are crucial in immune responses against viral infections and malignancies. Recent studies highlighted the heterogeneity of this ILC population and extended their functional spectrum to include important roles in tissue homeostasis and autoimmunity. In this article, we provide detailed profiling of NCR+T-bet+ ILC populations in the murine kidney, identifying conventional NK (cNK) cells and type 1 ILCs (ILC1s) as the two major subsets. Induction of renal inflammation in a mouse model of glomerulonephritis did not substantially influence abundance or phenotype of cNK cells or ILC1s in the kidney. For functional analyses in this model, widely used depletion strategies for total NCR+ ILCs (anti-NK1.1 Ab application) and cNK cells (anti-asialoGM1 serum application) were unreliable tools, because they were accompanied by significant off-target depletion of kidney NKT cells and CD8+ T cells, respectively. However, neither depletion of cNK cells and ILC1s in NKT cell–deficient mice nor specific genetic deletion of cNK cells in Ncr1Cre/wt × Eomesfl/fl mice altered the clinical course of experimental glomerulonephritis. In summary, we show in this article that cNK cells and ILC1s are dispensable for initiation and progression of immune-mediated glomerular disease and advise caution in the use of standard Ab depletion methods to study NCR+ ILC function in mouse models. Key Points The murine kidney harbors two distinct populations of NCR+T-bet+ ILCs. Transcriptomic profiling identifies these two populations as cNK cells and ILC1s. Depletion of NCR+T-bet+ ILCs does not influence pathogenesis of experimental cGN.

13 April 2026 in Cancer Discovery
Verified
Journal Article
Open access
HZHai-Feng Zhang
Hai-Feng Zhang
EDEdouard De Dreuzy
Edouard De Dreuzy
YHYue Zhou Huang
Yue Zhou Huang
SSSeungmin Shin
Seungmin Shin
QHQing-Feng Huang
Qing-Feng Huang
Poul H SorensenPoul H Sorensen
Poul H Sorensen
Gene fusions generated by chromosomal rearrangements function as oncogenic drivers in human cancers. We previously showed that EWSR1-ETS oncofusions of Ewing sarcoma (EwS) directly induce surface expression of IL1 receptor accessory protein (IL1RAP), which along with limited expression in healthy tissues except placenta nominate IL1RAP as a promising EwS immunotherapy target. We therefore engineered antibody-drug conjugates (ADCs) with different cytotoxic payloads to target IL1RAP. ADCs potently blocked tumor growth and induced durable regression of EwS xenografts in mice, and diminished metastatic dissemination in vivo. Moreover, we show that other oncofusions also induce IL1RAP expression in diverse cancers, including NPM-ALK in anaplastic large cell lymphoma (ALCL), and ETV6-NTRK3 in multiple tumor types. IL1RAP expression rendered these malignancies similarly vulnerable to IL1RAP-targeting ADCs, which effectively blocked growth of ALCL xenografts and syngeneic ETV6-NTRK3+ sarcomas. Lack of detectable normal tissue toxicity, including in non-human primates, support the further clinical translation of IL1RAP-targeting ADCs.

1 September 2026
Verified
Other
Open access
PDF file
HZHai-Feng Zhang
Hai-Feng Zhang
EDEdouard De Dreuzy
Edouard De Dreuzy
YHYue Zhou Huang
Yue Zhou Huang
SSSeungmin Shin
Seungmin Shin
QHQing-Feng Huang
Qing-Feng Huang
Poul H SorensenPoul H Sorensen
Poul H Sorensen
Supplementary Table S2. qPCR primers.

1 September 2026
Verified
Other
Open access
PDF file
HZHai-Feng Zhang
Hai-Feng Zhang
EDEdouard De Dreuzy
Edouard De Dreuzy
YHYue Zhou Huang
Yue Zhou Huang
SSSeungmin Shin
Seungmin Shin
QHQing-Feng Huang
Qing-Feng Huang
Poul H SorensenPoul H Sorensen
Poul H Sorensen
Supplementary Figure S9. Identification and characterization of AB030, a humanized IgG1 anti-IL1RAP binder for immunotherapy.